cyc 202 has been researched along with INDY in 2 studies
| Studies (cyc 202) | Trials (cyc 202) | Recent Studies (post-2010) (cyc 202) | Studies (INDY) | Trials (INDY) | Recent Studies (post-2010) (INDY) |
|---|---|---|---|---|---|
| 979 | 7 | 393 | 6 | 0 | 5 |
| Protein | Taxonomy | cyc 202 (IC50) | INDY (IC50) |
|---|---|---|---|
| Dual specificity tyrosine-phosphorylation-regulated kinase 1A | Homo sapiens (human) | 0.24 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bui, LC; Cariou, K; Dairou, J; Delabar, JM; Denhez, C; Dodd, RH; Gourdain, S; Janel, N; Rodrigues-Lima, F | 1 |
| Jarhad, DB; Jeong, LS; Kim, HR; Mashelkar, KK; Noh, M | 1 |
1 review(s) available for cyc 202 and INDY
| Article | Year |
|---|---|
Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 1A (DYRK1A) Inhibitors as Potential Therapeutics.
Topics: Animals; Biological Products; Disease; Dyrk Kinases; Enzyme Activation; Humans; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases | 2018 |
1 other study(ies) available for cyc 202 and INDY
| Article | Year |
|---|---|
Development of DANDYs, new 3,5-diaryl-7-azaindoles demonstrating potent DYRK1A kinase inhibitory activity.
Topics: Dyrk Kinases; Enzyme Inhibitors; Humans; Hydrogen Bonding; Indoles; KB Cells; Molecular Docking Simulation; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Pyridines | 2013 |